#,ama,title,journal,year,volume,issue,pages,doi,pmid,authors
1,"Badillo R, Rockey DC. Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature. Medicine. 2014;93(3).","Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature",Medicine,2014,93,3,,,,Badillo R; Rockey DC
2,"Kinasewitz GT, Keddissi JI. Hepatic hydrothorax. Curr Opin Pulm Med. 2003;9(4).",Hepatic hydrothorax,Curr Opin Pulm Med,2003,9,4,,,,Kinasewitz GT; Keddissi JI
3,"Dhanasekaran R, West JK, Gonzales PC. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis. Am J Gastroenterol. 2010;105(3).",Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis,Am J Gastroenterol,2010,105,3,,,,Dhanasekaran R; West JK; Gonzales PC
4,"Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rossle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol. 2001;13(5).",Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients,Eur J Gastroenterol Hepatol,2001,13,5,,,,Siegerstetter V; Deibert P; Ochs A; Olschewski M; Blum HE; Rossle M
5,"Spencer EB, Cohen DT, Darcy MD. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax. J Vasc Interv Radiol. 2002;13(4).",Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax,J Vasc Interv Radiol,2002,13,4,,,,Spencer EB; Cohen DT; Darcy MD
6,"Everhart JE, Lombardero M, Detre KM. Increased waiting time for liver transplantation results in higher mortality. Transplantation. 1997;64(9).",Increased waiting time for liver transplantation results in higher mortality,Transplantation,1997,64,9,,,,Everhart JE; Lombardero M; Detre KM
7,"Lucey MR, Brown KA, Everson GT. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation. 1998;66(7).",Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases,Transplantation,1998,66,7,,,,Lucey MR; Brown KA; Everson GT
8,"Liu LU, Haddadin HA, Bodian CA. Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest. 2004;126(1).",Outcome analysis of cirrhotic patients undergoing chest tube placement,Chest,2004,126,1,,,,Liu LU; Haddadin HA; Bodian CA
9,"Runyon BA, Greenblatt M, Ming RH. Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol. 1986;81(7).",Hepatic hydrothorax is a relative contraindication to chest tube insertion,Am J Gastroenterol,1986,81,7,,,,Runyon BA; Greenblatt M; Ming RH
10,"Orman ES, Lok AS. Outcomes of patients with chest tube insertion for hepatic hydrothorax. Hepatol Int. 2009;3(4).",Outcomes of patients with chest tube insertion for hepatic hydrothorax,Hepatol Int,2009,3,4,,,,Orman ES; Lok AS
11,"Davies HE, Mishra EK, Kahan BC. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA. 2012;307(22).",Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial,JAMA,2012,307,22,,,,Davies HE; Mishra EK; Kahan BC
12,"Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest. 2006;129(2).",Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion,Chest,2006,129,2,,,,Tremblay A; Michaud G
13,"Majid A, Kheir F, Fashjian M. Tunneled pleural catheter placement with and without talc poudrage for treatment of pleural effusions due to congestive heart failure. Ann Am Thorac Soc. 2016;13(2).",Tunneled pleural catheter placement with and without talc poudrage for treatment of pleural effusions due to congestive heart failure,Ann Am Thorac Soc,2016,13,2,,,,Majid A; Kheir F; Fashjian M
14,"Chen A, Massoni J, Jung D, Crippin J. Indwelling tunneled pleural catheters for the management of hepatic hydrothorax. A pilot study. Ann Am Thorac Soc. 2016;13(6).",Indwelling tunneled pleural catheters for the management of hepatic hydrothorax. A pilot study,Ann Am Thorac Soc,2016,13,6,,,,Chen A; Massoni J; Jung D; Crippin J
15,"Mercky P, Sakr L, Heyries L, Lagrange X, Sahel J, Dutau H. Use of a tunnelled pleural catheter for the management of refractory hepatic hydrothorax: a new therapeutic option. Respiration. 2010;80(4).",Use of a tunnelled pleural catheter for the management of refractory hepatic hydrothorax: a new therapeutic option,Respiration,2010,80,4,,,,Mercky P; Sakr L; Heyries L; Lagrange X; Sahel J; Dutau H
16,"Shojaee S, Khalid M, Kallingal GJ, Kang L, Rahman NM. Repeat thoracentesis in hepatic hydrothorax and non-hepatic hydrothorax effusions: a case control study. Repeat thoracentesis in hepatic hydrothorax and non-hepatic hydrothorax effusions: a case control study. None;None. doi:10.1159/000490001.",Repeat thoracentesis in hepatic hydrothorax and non-hepatic hydrothorax effusions: a case control study,Repeat thoracentesis in hepatic hydrothorax and non-hepatic hydrothorax effusions: a case control study,,,,,10.1159/000490001,,Shojaee S; Khalid M; Kallingal GJ; Kang L; Rahman NM
17,"Singh A, Bajwa A, Shujaat A. Evidencebased review of the management of hepatic hydrothorax. Respiration. 2013;86(2).",Evidencebased review of the management of hepatic hydrothorax,Respiration,2013,86,2,,,,Singh A; Bajwa A; Shujaat A
18,"Fysh ET, Tremblay A, Feller-Kopman D. Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study. Chest. 2013;144(5).",Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study,Chest,2013,144,5,,,,Fysh ET; Tremblay A; Feller-Kopman D
19,"Mekhaiel E, Kashyap R, Mullon JJ, Maldonado F. Infections associated with tunnelled indwelling pleural catheters in patients undergoing chemotherapy. J Bronchology Interv Pulmonol. 2013;20(4).",Infections associated with tunnelled indwelling pleural catheters in patients undergoing chemotherapy,J Bronchology Interv Pulmonol,2013,20,4,,,,Mekhaiel E; Kashyap R; Mullon JJ; Maldonado F
20,"Bhatnagar R, Reid ED, Corcoran JP. Indwelling pleural catheters for non-malignant effusions: a multicentre review of practice. Thorax. 2014;69(10).",Indwelling pleural catheters for non-malignant effusions: a multicentre review of practice,Thorax,2014,69,10,,,,Bhatnagar R; Reid ED; Corcoran JP
21,"Patil M, Dhillon SS, Attwood K, Saoud M, Alraiyes AH, Harris K. Management of benign pleural effusions using indwelling pleural catheters: a systematic review and meta-analysis. Chest. 2017;151(3).",Management of benign pleural effusions using indwelling pleural catheters: a systematic review and meta-analysis,Chest,2017,151,3,,,,Patil M; Dhillon SS; Attwood K; Saoud M; Alraiyes AH; Harris K
22,"Kniese C, Diab K, Ghabril M, Bosslet G. Indwelling pleural catheters in hepatic hydrothorax: a single-center series of outcomes and complications. Chest. 2019;155(2).",Indwelling pleural catheters in hepatic hydrothorax: a single-center series of outcomes and complications,Chest,2019,155,2,,,,Kniese C; Diab K; Ghabril M; Bosslet G
23,"Kwosk CS, Krupa L, Mahtani A. Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysis. Biomed Res Int. 2013;2013:295153.",Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysis,Biomed Res Int,2013,2013,,295153,,,Kwosk CS; Krupa L; Mahtani A
